Kits with the affected products may not be able to fully extract nucleic acids from samples and detect infection or provide a correct diagnosis.
Companies with diverse infectious disease diagnostic technology offerings said that molecular methods are complementary to, not competitive with traditional diagnostics.
FilmArray drove business growth in molecular biology, contributing €80 million to Q4 revenues and €249 million to FY 2016 revenues.
The firm's GI panel has also been recently evaluated in pediatric populations, demonstrating a marked increase in overall pathogen detection.
The report focused on identification of filamentous fungi and mycobacteria, and testing for resistance and susceptibility to antibiotics.
The analyses found solid evidence that MALDI-based clinical microbiology systems bettered patient care, but effects on hospital costs were less clear.
During the company's third quarter earnings call, CEO Mark Casper highlighted a number of recent clinical and diagnostic product launches and initiatives.
The firm also reported a 46 percent increase in molecular biology sales due to growth in its FilmArray line.
The test detects 11 viruses and three bacterial pathogens in approximately one hour and requires two minutes of hands-on time.
The research aims to validate new predictive tests that would enable development of diagnostic and therapeutic solutions to fight sepsis.
In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.
Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.
Researchers are using gene editing to develop more robust livestock and crops, AFP reports.
Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.